Loading cancer entity…
Loading cancer entity…
Clinical trials
17 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07797270 | Ultrasound-Guided Emulsification Therapy in the Clinical Treatment of Subcutaneous Lipomas | not yet recruiting | N/A | 30 | Chinese PLA General HospitalOTHER | 0 | Sep 1, 2026 | clinicaltrials |
| NCT06903208 | RFA for Superficial Lipomas | recruiting | N/A | 10 | Columbia UniversityOTHER | 1 | Aug 14, 2026 | clinicaltrials |
| NCT07734805 | Radiological Diagnosis of Pediatric Neck Swellings | active not recruiting | — | 50 | Sohag UniversityOTHER | 1 | Jul 30, 2026 | clinicaltrials |
| NCT07237425 | Intralesional Ronkyla Plus Injection for the Treatment of Superficial Lipoma |
Data updated 21 days agoSource updated Sep 1, 2026source: clinicaltrials
| Phase 1 |
| 56 |
| Glonova Pharma Co., LtdINDUSTRY |
| 1 |
| Jul 28, 2026 |
| clinicaltrials |
| NCT06820164 | Lipomas Treated With Subcutaneous Injections of Cooled or Warmed Sodium Chloride | recruiting | Phase 1 / Phase 2 | 20 | West Virginia UniversityOTHER | 1 | Apr 29, 2026 | clinicaltrials |
| NCT07014163 | Evaluating the Efficacy and Safety of Embella (Deoxycholic Acid, Produced by Espad Pharmed Co.) Injection in the Management of Superficial Lipomas | recruiting | N/A | 10 | Espad PharmedINDUSTRY | 1 | Jun 10, 2025 | clinicaltrials |